When injections and pills are counter-indicated, transdermal and transmucosal delivery systems may get drugs into the body with great efficacy and beneficial results.
This report aims to provide a comprehensive presentation of the global market for Transdermal and Transmucosal Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal and Transmucosal Drug Delivery. This report contains market size and forecasts of Transdermal and Transmucosal Drug Delivery in global, including the following market information:
Global Transdermal and Transmucosal Drug Delivery Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Transdermal and Transmucosal Drug Delivery market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Transdermal Drug Delivery Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Transdermal and Transmucosal Drug Delivery include 3M, Antares Pharma, Aveva Drug Delivery Systems, Corium International, DURECT, Pantec Biosolutions, Tapemark and Tesa Labtec, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Transdermal and Transmucosal Drug Delivery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Transdermal and Transmucosal Drug Delivery Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Transdermal and Transmucosal Drug Delivery Market Segment Percentages, by Type, 2022 (%)
Transdermal Drug Delivery
Transmucosal Drug Delivery
Global Transdermal and Transmucosal Drug Delivery Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Transdermal and Transmucosal Drug Delivery Market Segment Percentages, by Application, 2022 (%)
Clinics
Hospitals
Others
Global Transdermal and Transmucosal Drug Delivery Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Transdermal and Transmucosal Drug Delivery Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Transdermal and Transmucosal Drug Delivery revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Transdermal and Transmucosal Drug Delivery revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
3M
Antares Pharma
Aveva Drug Delivery Systems
Corium International
DURECT
Pantec Biosolutions
Tapemark
Tesa Labtec
Outline of Major Chapters:
Chapter 1: Introduces the definition of Transdermal and Transmucosal Drug Delivery, market overview.
Chapter 2: Global Transdermal and Transmucosal Drug Delivery market size in revenue.
Chapter 3: Detailed analysis of Transdermal and Transmucosal Drug Delivery company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Transdermal and Transmucosal Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Transdermal and Transmucosal Drug Delivery Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Transdermal and Transmucosal Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Transdermal and Transmucosal Drug Delivery Overall Market Size
2.1 Global Transdermal and Transmucosal Drug Delivery Market Size: 2022 VS 2029
2.2 Global Transdermal and Transmucosal Drug Delivery Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Transdermal and Transmucosal Drug Delivery Players in Global Market
3.2 Top Global Transdermal and Transmucosal Drug Delivery Companies Ranked by Revenue
3.3 Global Transdermal and Transmucosal Drug Delivery Revenue by Companies
3.4 Top 3 and Top 5 Transdermal and Transmucosal Drug Delivery Companies in Global Market, by Revenue in 2022
3.5 Global Companies Transdermal and Transmucosal Drug Delivery Product Type
3.6 Tier 1, Tier 2 and Tier 3 Transdermal and Transmucosal Drug Delivery Players in Global Market
3.6.1 List of Global Tier 1 Transdermal and Transmucosal Drug Delivery Companies
3.6.2 List of Global Tier 2 and Tier 3 Transdermal and Transmucosal Drug Delivery Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Transdermal and Transmucosal Drug Delivery Market Size Markets, 2022 & 2029
4.1.2 Transdermal Drug Delivery
4.1.3 Transmucosal Drug Delivery
4.2 By Type - Global Transdermal and Transmucosal Drug Delivery Revenue & Forecasts
4.2.1 By Type - Global Transdermal and Transmucosal Drug Delivery Revenue, 2018-2023
4.2.2 By Type - Global Transdermal and Transmucosal Drug Delivery Revenue, 2024-2029
4.2.3 By Type - Global Transdermal and Transmucosal Drug Delivery Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Transdermal and Transmucosal Drug Delivery Market Size, 2022 & 2029
5.1.2 Clinics
5.1.3 Hospitals
5.1.4 Others
5.2 By Application - Global Transdermal and Transmucosal Drug Delivery Revenue & Forecasts
5.2.1 By Application - Global Transdermal and Transmucosal Drug Delivery Revenue, 2018-2023
5.2.2 By Application - Global Transdermal and Transmucosal Drug Delivery Revenue, 2024-2029
5.2.3 By Application - Global Transdermal and Transmucosal Drug Delivery Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Transdermal and Transmucosal Drug Delivery Market Size, 2022 & 2029
6.2 By Region - Global Transdermal and Transmucosal Drug Delivery Revenue & Forecasts
6.2.1 By Region - Global Transdermal and Transmucosal Drug Delivery Revenue, 2018-2023
6.2.2 By Region - Global Transdermal and Transmucosal Drug Delivery Revenue, 2024-2029
6.2.3 By Region - Global Transdermal and Transmucosal Drug Delivery Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Transdermal and Transmucosal Drug Delivery Revenue, 2018-2029
6.3.2 US Transdermal and Transmucosal Drug Delivery Market Size, 2018-2029
6.3.3 Canada Transdermal and Transmucosal Drug Delivery Market Size, 2018-2029
6.3.4 Mexico Transdermal and Transmucosal Drug Delivery Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Transdermal and Transmucosal Drug Delivery Revenue, 2018-2029
6.4.2 Germany Transdermal and Transmucosal Drug Delivery Market Size, 2018-2029
6.4.3 France Transdermal and Transmucosal Drug Delivery Market Size, 2018-2029
6.4.4 U.K. Transdermal and Transmucosal Drug Delivery Market Size, 2018-2029
6.4.5 Italy Transdermal and Transmucosal Drug Delivery Market Size, 2018-2029
6.4.6 Russia Transdermal and Transmucosal Drug Delivery Market Size, 2018-2029
6.4.7 Nordic Countries Transdermal and Transmucosal Drug Delivery Market Size, 2018-2029
6.4.8 Benelux Transdermal and Transmucosal Drug Delivery Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Transdermal and Transmucosal Drug Delivery Revenue, 2018-2029
6.5.2 China Transdermal and Transmucosal Drug Delivery Market Size, 2018-2029
6.5.3 Japan Transdermal and Transmucosal Drug Delivery Market Size, 2018-2029
6.5.4 South Korea Transdermal and Transmucosal Drug Delivery Market Size, 2018-2029
6.5.5 Southeast Asia Transdermal and Transmucosal Drug Delivery Market Size, 2018-2029
6.5.6 India Transdermal and Transmucosal Drug Delivery Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Transdermal and Transmucosal Drug Delivery Revenue, 2018-2029
6.6.2 Brazil Transdermal and Transmucosal Drug Delivery Market Size, 2018-2029
6.6.3 Argentina Transdermal and Transmucosal Drug Delivery Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Transdermal and Transmucosal Drug Delivery Revenue, 2018-2029
6.7.2 Turkey Transdermal and Transmucosal Drug Delivery Market Size, 2018-2029
6.7.3 Israel Transdermal and Transmucosal Drug Delivery Market Size, 2018-2029
6.7.4 Saudi Arabia Transdermal and Transmucosal Drug Delivery Market Size, 2018-2029
6.7.5 UAE Transdermal and Transmucosal Drug Delivery Market Size, 2018-2029
7 Transdermal and Transmucosal Drug Delivery Companies Profiles
7.1 3M
7.1.1 3M Company Summary
7.1.2 3M Business Overview
7.1.3 3M Transdermal and Transmucosal Drug Delivery Major Product Offerings
7.1.4 3M Transdermal and Transmucosal Drug Delivery Revenue in Global Market (2018-2023)
7.1.5 3M Key News & Latest Developments
7.2 Antares Pharma
7.2.1 Antares Pharma Company Summary
7.2.2 Antares Pharma Business Overview
7.2.3 Antares Pharma Transdermal and Transmucosal Drug Delivery Major Product Offerings
7.2.4 Antares Pharma Transdermal and Transmucosal Drug Delivery Revenue in Global Market (2018-2023)
7.2.5 Antares Pharma Key News & Latest Developments
7.3 Aveva Drug Delivery Systems
7.3.1 Aveva Drug Delivery Systems Company Summary
7.3.2 Aveva Drug Delivery Systems Business Overview
7.3.3 Aveva Drug Delivery Systems Transdermal and Transmucosal Drug Delivery Major Product Offerings
7.3.4 Aveva Drug Delivery Systems Transdermal and Transmucosal Drug Delivery Revenue in Global Market (2018-2023)
7.3.5 Aveva Drug Delivery Systems Key News & Latest Developments
7.4 Corium International
7.4.1 Corium International Company Summary
7.4.2 Corium International Business Overview
7.4.3 Corium International Transdermal and Transmucosal Drug Delivery Major Product Offerings
7.4.4 Corium International Transdermal and Transmucosal Drug Delivery Revenue in Global Market (2018-2023)
7.4.5 Corium International Key News & Latest Developments
7.5 DURECT
7.5.1 DURECT Company Summary
7.5.2 DURECT Business Overview
7.5.3 DURECT Transdermal and Transmucosal Drug Delivery Major Product Offerings
7.5.4 DURECT Transdermal and Transmucosal Drug Delivery Revenue in Global Market (2018-2023)
7.5.5 DURECT Key News & Latest Developments
7.6 Pantec Biosolutions
7.6.1 Pantec Biosolutions Company Summary
7.6.2 Pantec Biosolutions Business Overview
7.6.3 Pantec Biosolutions Transdermal and Transmucosal Drug Delivery Major Product Offerings
7.6.4 Pantec Biosolutions Transdermal and Transmucosal Drug Delivery Revenue in Global Market (2018-2023)
7.6.5 Pantec Biosolutions Key News & Latest Developments
7.7 Tapemark
7.7.1 Tapemark Company Summary
7.7.2 Tapemark Business Overview
7.7.3 Tapemark Transdermal and Transmucosal Drug Delivery Major Product Offerings
7.7.4 Tapemark Transdermal and Transmucosal Drug Delivery Revenue in Global Market (2018-2023)
7.7.5 Tapemark Key News & Latest Developments
7.8 Tesa Labtec
7.8.1 Tesa Labtec Company Summary
7.8.2 Tesa Labtec Business Overview
7.8.3 Tesa Labtec Transdermal and Transmucosal Drug Delivery Major Product Offerings
7.8.4 Tesa Labtec Transdermal and Transmucosal Drug Delivery Revenue in Global Market (2018-2023)
7.8.5 Tesa Labtec Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Transdermal and Transmucosal Drug Delivery Market Opportunities & Trends in Global Market
Table 2. Transdermal and Transmucosal Drug Delivery Market Drivers in Global Market
Table 3. Transdermal and Transmucosal Drug Delivery Market Restraints in Global Market
Table 4. Key Players of Transdermal and Transmucosal Drug Delivery in Global Market
Table 5. Top Transdermal and Transmucosal Drug Delivery Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Transdermal and Transmucosal Drug Delivery Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Transdermal and Transmucosal Drug Delivery Revenue Share by Companies, 2018-2023
Table 8. Global Companies Transdermal and Transmucosal Drug Delivery Product Type
Table 9. List of Global Tier 1 Transdermal and Transmucosal Drug Delivery Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Transdermal and Transmucosal Drug Delivery Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Transdermal and Transmucosal Drug Delivery Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Transdermal and Transmucosal Drug Delivery Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Transdermal and Transmucosal Drug Delivery Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Transdermal and Transmucosal Drug Delivery Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Transdermal and Transmucosal Drug Delivery Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Transdermal and Transmucosal Drug Delivery Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 30. 3M Company Summary
Table 31. 3M Transdermal and Transmucosal Drug Delivery Product Offerings
Table 32. 3M Transdermal and Transmucosal Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 33. 3M Key News & Latest Developments
Table 34. Antares Pharma Company Summary
Table 35. Antares Pharma Transdermal and Transmucosal Drug Delivery Product Offerings
Table 36. Antares Pharma Transdermal and Transmucosal Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 37. Antares Pharma Key News & Latest Developments
Table 38. Aveva Drug Delivery Systems Company Summary
Table 39. Aveva Drug Delivery Systems Transdermal and Transmucosal Drug Delivery Product Offerings
Table 40. Aveva Drug Delivery Systems Transdermal and Transmucosal Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 41. Aveva Drug Delivery Systems Key News & Latest Developments
Table 42. Corium International Company Summary
Table 43. Corium International Transdermal and Transmucosal Drug Delivery Product Offerings
Table 44. Corium International Transdermal and Transmucosal Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 45. Corium International Key News & Latest Developments
Table 46. DURECT Company Summary
Table 47. DURECT Transdermal and Transmucosal Drug Delivery Product Offerings
Table 48. DURECT Transdermal and Transmucosal Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 49. DURECT Key News & Latest Developments
Table 50. Pantec Biosolutions Company Summary
Table 51. Pantec Biosolutions Transdermal and Transmucosal Drug Delivery Product Offerings
Table 52. Pantec Biosolutions Transdermal and Transmucosal Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 53. Pantec Biosolutions Key News & Latest Developments
Table 54. Tapemark Company Summary
Table 55. Tapemark Transdermal and Transmucosal Drug Delivery Product Offerings
Table 56. Tapemark Transdermal and Transmucosal Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 57. Tapemark Key News & Latest Developments
Table 58. Tesa Labtec Company Summary
Table 59. Tesa Labtec Transdermal and Transmucosal Drug Delivery Product Offerings
Table 60. Tesa Labtec Transdermal and Transmucosal Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 61. Tesa Labtec Key News & Latest Developments
List of Figures
Figure 1. Transdermal and Transmucosal Drug Delivery Segment by Type in 2022
Figure 2. Transdermal and Transmucosal Drug Delivery Segment by Application in 2022
Figure 3. Global Transdermal and Transmucosal Drug Delivery Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Transdermal and Transmucosal Drug Delivery Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Transdermal and Transmucosal Drug Delivery Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Transdermal and Transmucosal Drug Delivery Revenue in 2022
Figure 8. By Type - Global Transdermal and Transmucosal Drug Delivery Revenue Market Share, 2018-2029
Figure 9. By Application - Global Transdermal and Transmucosal Drug Delivery Revenue Market Share, 2018-2029
Figure 10. By Type - Global Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Transdermal and Transmucosal Drug Delivery Revenue Market Share, 2018-2029
Figure 12. By Application - Global Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Transdermal and Transmucosal Drug Delivery Revenue Market Share, 2018-2029
Figure 14. By Region - Global Transdermal and Transmucosal Drug Delivery Revenue Market Share, 2018-2029
Figure 15. By Country - North America Transdermal and Transmucosal Drug Delivery Revenue Market Share, 2018-2029
Figure 16. US Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Transdermal and Transmucosal Drug Delivery Revenue Market Share, 2018-2029
Figure 20. Germany Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 21. France Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Transdermal and Transmucosal Drug Delivery Revenue Market Share, 2018-2029
Figure 28. China Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 32. India Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Transdermal and Transmucosal Drug Delivery Revenue Market Share, 2018-2029
Figure 34. Brazil Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Transdermal and Transmucosal Drug Delivery Revenue Market Share, 2018-2029
Figure 37. Turkey Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Transdermal and Transmucosal Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 41. 3M Transdermal and Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Antares Pharma Transdermal and Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Aveva Drug Delivery Systems Transdermal and Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Corium International Transdermal and Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. DURECT Transdermal and Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Pantec Biosolutions Transdermal and Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Tapemark Transdermal and Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Tesa Labtec Transdermal and Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
